Trial Profile
The effect of mirtazapine (REMERGON) on gastric motility and satiation in healthy subjects
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Mar 2021
Price :
$35
*
At a glance
- Drugs Mirtazapine (Primary)
- Indications Fibromyalgia; Major depressive disorder
- Focus Pharmacodynamics
- 11 Mar 2021 Status changed from recruiting to completed.
- 25 Apr 2015 New trial record